Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-09

FDA Approved: NABUMETONE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for Nabumetone from ScieGen Pharmaceuticals Inc. The action updates the product's labeling based on the supplemental sub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)